Individualization of drug therapy for the parkinsonian patient.
D000978:Antiparkinson Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001146:Arrhythmia, Sinus / Q000139:chemically induced; D001812:Blood-Brain Barrier; D003680:Deglutition Disorders / Q000175:diagnosis; D004347:Drug Interactions; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D007024:Hypotension, Orthostatic / Q000139:chemically induced; D007980:Levodopa / Q000009:adverse effects / Q000627:therapeutic use*; D010276:Parasympatholytics / Q000627:therapeutic use; D010300:Parkinson Disease / Q000175:diagnosis / Q000188:drug therapy*
D000978:Antiparkinson Agents; D006634:Histamine H1 Antagonists; D010276:Parasympatholytics; D007980:Levodopa